BIOMAT Database Logo BIOMAT Database Logo

A Validated Method to Prepare Stable Tau Oligomers. 2023

Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
School of Life Sciences, University of Warwick, Coventry, UK.

There is growing evidence that tau oligomers are a major pathological species in a number of tauopathies including Alzheimer's disease. However, it is still unclear what exact mechanisms underlie tau oligomer-mediated dysfunction. Studies of tau oligomers in vitro are limited by the high propensity for aggregation and consequent changes in the aggregation state of the produced tau samples over time. In this protocol, we provide a step-by-step description of a validated method for producing stable and structurally characterized oligomers of tau that can be used in biochemical, cellular, and animal model studies to evaluate mechanisms of action of tau in tauopathies.

UI MeSH Term Description Entries
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D024801 Tauopathies Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration. Tauopathy

Related Publications

Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Tau Oligomers.
January 2019, Advances in experimental medicine and biology,
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Formation, release, and internalization of stable tau oligomers in cells.
December 2016, Journal of neurochemistry,
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses.
November 2012, Brain pathology (Zurich, Switzerland),
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Organogold oligomers: exploiting iClick and aurophilic cluster formation to prepare solution stable Auâ‚„ repeating units.
July 2015, Dalton transactions (Cambridge, England : 2003),
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Fusion of bolaamphiphile micelles: a method to prepare stable supported biomimetic membranes.
January 2013, Langmuir : the ACS journal of surfaces and colloids,
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Tau Oligomers Neurotoxicity.
January 2021, Life (Basel, Switzerland),
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
New method to prepare very stable and biocompatible fluorescent silica nanoparticles.
May 2009, Chemical communications (Cambridge, England),
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Tau oligomers are linked to m6A-RNA.
October 2021, Nature reviews. Molecular cell biology,
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Hyperphosphorylation-induced tau oligomers.
January 2013, Frontiers in neurology,
Emily Hill, and Kevin G Moffat, and Mark J Wall, and Henrik Zetterberg, and Kaj Blennow, and Thomas K Karikari
Tauopathies and tau oligomers.
January 2013, Journal of Alzheimer's disease : JAD,
Copied contents to your clipboard!